Data protection Impressum

Life sciences

LEM Surgical, a leader in surgical robotics, has opened a state-of-the-art 19,400-square-foot headquarters in Bern, Switzerland.

LEM Surgical unveils new headquarters in Bern to advance surgical robotics

3 September 2024

Biotech Vandria has raised an additional CHF 14 million to accelerate the development of innovative treatments for age-related and chronic diseases, bringing its total Series A financing to CHF 28.3 million.

Vandria secures over CHF 14 million to advance age-related disease therapies

3 September 2024

Scientists from the University of Geneva and the University of Fribourg have made significant strides in understanding how yeast cells sense and respond to physical stress on their membranes, shedding light on the critical role of membrane dynamics in cell survival.

UNIFR and UNIGE collaborate on breakthrough research in cell membrane dynamics

14 August 2024

Relief Therapeutics has entered into an agreement with SWK Funding LLC to secure up to USD 11 million in non-dilutive financing through the sale of royalty interests to support its clinical development pipeline.

Geneva biotech Relief Therapeutics raises up to USD 11 million from royalty sales

14 August 2024

Release Therapeutics has raised CHF 3.3 million in seed funding to advance its innovative approach to treating metachromatic leukodystrophy (MLD), a rare genetic disorder affecting young children.

Release Therapeutics secures CHF 3.3 million to advance MLD research

13 August 2024

CSEM, along with start-ups Impli and Yalosys, has developed CERES, an implantable biosensor for real-time fertility hormone monitoring.

CSEM develops a pioneering implant to support reproductive medicine

7 August 2024

Oryl Photonics has joined the Fast and Accurate Solubility for Sustainability (FASS) project, receiving a EUR 2.5 million EIC Transition grant to develop a novel laboratory instrument for drug solubility measurement.

EPFL spin-off Oryl Photonics joins a EUR 2.5 million European project

7 August 2024

AC Immune’s ACI-35.030 (now called JNJ-2056), an active-immunotherapy candidate targeting the pathologic form of the Tau protein, has received Fast Track designation from the U.S. Food and Drug Administration (FDA).

AC Immune receives FDA Fast Track designation for Alzheimer’s disease therapy

6 August 2024

Geneva-based Agora Care has closed a financing round of CHF 2.2 million to support its expansion into the US market and increase patient enrollment in Switzerland and Europe.

Medical imaging specialist Agora Care secures CHF 2.2 million for US market expansion

5 August 2024

Biopôle is joining forces with Swiss Healthcare Startups to extend the Vanguard accelerator to digital health start-ups in German-speaking Switzerland, while also welcoming Hôpital de La Tour to its Corporate Partnership Programme.

Biopôle expands its accelerator program and welcomes new corporate partner

5 August 2024

1 2 3 4 5 6 … 35